MedPath

Laparoscopic Adjustable Gastric Banding Versus Laparoscopic Sleeve Gastrectomy

Phase 3
Completed
Conditions
Morbid Obesity
Registration Number
NCT00434655
Lead Sponsor
North Texas Veterans Healthcare System
Brief Summary

* The investigators aim to determine the clinical and metabolic outcomes of two available bariatric restrictive procedures: laparoscopic adjustable gastric banding (LAP-BAND) and laparoscopic sleeve gastrectomy for the treatment of morbid obesity (BMI \> 35 with comorbidities or BMI \> 40) in VETERANS.

* The investigators hypothesize that the short and long term outcomes between laparoscopic adjustable gastric banding (LAP-BAND) and sleeve gastrectomy are similar in VETERANS.

Detailed Description

This is a bariatric surgery Phase 3 prospective trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Morbidly obese VETERANS ONLY (BMI>35 with comorbidities or BMI > 40)
  • Age > 18 y/o
Exclusion Criteria
  • Pregnancy
  • Severe uncontrolled medical or psychiatric conditions
  • Previous bariatric surgery
  • Multiple previous abdominal surgeries

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Short and long term clinical outcomes5 years
Secondary Outcome Measures
NameTimeMethod
Metabolic outcomes5 years
Esophago-gastric physiology2 years
Hormonal physiology5 years
Procedure costs5 years

Trial Locations

Locations (1)

VA North Texas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

VA North Texas
πŸ‡ΊπŸ‡ΈDallas, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.